CME/CE
Your professional development is critical to the care of your patients. Stay on top of the latest treatments and information with ReachMD's CME activities. Our topics span cardiology, diabetes, oncology, women's health and more. And our CME library is continuously growing, every quarter.
241-255 of 1187
The Neverending Journey: A 66-Year-Old Patient Who Has Undergone Several Rounds of Tea Tree Oil–Based Treatment
MinuteCE®The Neverending Journey: A 66-Year-Old Patient Who Has Undergone Several Rounds of Tea Tree Oil–Based Treatment
Return and Revisit: A 38-Year-Old Patient Returns for Follow-up After Lotilaner Treatment
MinuteCE®Return and Revisit: A 38-Year-Old Patient Returns for Follow-up After Lotilaner Treatment
Closing the Loop: Structured Follow-Up and Patient Communication
MinuteCE®Closing the Loop: Structured Follow-Up and Patient Communication
NPS Psychosis: Circuits, Treatment, and New Hope
MinuteCE®NPS Psychosis: Circuits, Treatment, and New Hope
Neuroinflammation to Network Instability: Translating FAAH/MAGL Biology to NPS
MinuteCE®Neuroinflammation to Network Instability: Translating FAAH/MAGL Biology to NPS
Living With Systemic Mastocytosis: Bridging Clinical Decisions and Patient Realities
CME/CELiving With Systemic Mastocytosis: Bridging Clinical Decisions and Patient Realities
- advertisement
Precision Strikes in AML: Navigating the Evolving Landscape of Targeted Therapies
CME/CEPrecision Strikes in AML: Navigating the Evolving Landscape of Targeted Therapies
Grooving Through Lipid Management: A New Rhythm in ASCVD Risk Reduction
CME/CEGrooving Through Lipid Management: A New Rhythm in ASCVD Risk Reduction
Hidden in Plain Sight: A Modern Guide to Detecting and Managing Early Neurotrophic Keratitis
CME/CEHidden in Plain Sight: A Modern Guide to Detecting and Managing Early Neurotrophic Keratitis
Beyond IOP: Integrating Ocular Surface Resilience Into Glaucoma Management
CME/CEBeyond IOP: Integrating Ocular Surface Resilience Into Glaucoma Management
Vous prescrivez uniquement des antihistaminiques pour traiter les patients atteints de Pa-MRC ? Il est temps de revoir votre approche !
CME/CEVous prescrivez uniquement des antihistaminiques pour traiter les patients atteints de Pa-MRC ? Il est temps de revoir votre approche !
Retina Rumble: Debating Modern Treatment Options
CME/CERetina Rumble: Debating Modern Treatment Options
- advertisement
Enhancing Collaborative Care in Retinal Diseases: A Focus on Injection Therapies
CME/CE Broadcast ReplayEnhancing Collaborative Care in Retinal Diseases: A Focus on Injection Therapies
A Seat at the HS Expert’s Table: A Master Class in Diagnosis and Treatment Advances for Hidradenitis Suppurativa
CME/CEA Seat at the HS Expert’s Table: A Master Class in Diagnosis and Treatment Advances for Hidradenitis Suppurativa
Leveraging CGM to Its Full Potential in People with T2D
CME/CELeveraging CGM to Its Full Potential in People with T2D





















































































